About Olivier Jarry
Olivier Jarry is a director at OS Therapies.
Form D filings also name Olivier Jarry as an executive officer at Klothea BIO.
Olivier Jarry reports to the SEC as a director or officer of 3 public companies, including DarioHealth (DRIO) and Precigen (PGEN).
Olivier Jarry first appears on SEC filings in 2015.
Experience
This experience comes from Olivier Jarry's profile and from SEC filings. For roles taken from filings, the years are when the filings name Olivier Jarry in the role, so the role may have started earlier or lasted longer.
OS Therapies Inc Current
Non Executive Director (2024 – Present)
Director
2024 – Present · Public company (OSTX)
Klothea Bio, Inc. Current
Chief Operating Officer
2024 – Present · Miami, FL
Develops experimental treatments for people affected by age-related diseases.
AI
ADvantage Therapeutics Inc. Current
Chief Operating Officer
2023 – Present
RV
Rational Vaccines Current
Chief Operating Officer (& CFO, CQO)
2021 – Present
AL
Atlas Advisors, LLC Current
Managing Director
2020 – Present
LI
LiberaBio Current
Co-Founder & Business Development Head
2018 – Present
EF
Executive Forum
Member (formerly Board Member)
2011 – 2023
AA
American Diabetes Association
Board Member NY/NJ
2019 – 2021
I3
IMAGIANCE LLC (dba 3xBL)
Managing Partner - Life Sciences, Market Research, Global Access-to-Medicines, SDG
2011 – 2021
DC
DarioHealth Corp.
President & Chief Commercial Officer
2016 – 2020 · Public company (DRIO)
FC
Forbes Councils
Member
2020
CS
Columbia Capital Securities
Senior Advisor (Investment Banking, Life Sciences)
2017 – 2020
LT
LIFNano Therapeutics
Non-Executive Director (Board Member) - Business Development & Alliance
2016 – 2019
EC
Enterprise Analysis Corporation
Senior Adviser - Pharmaceuticals Consulting, Market Access, Product Launches, Health Economics
2014 – 2018
FC
Fit4D, Personalized Diabetes Coaching
Advisory Board Member
2013 – 2018
SK
Skipta
Partner Skipta Global
2013 – 2017
IC
Intrexon Corporation
SVP Consumer Sector
2015 – 2016
PI
Precigen, Inc.
SVP--Consumer Sector
2015 · Public company (PGEN)
BS
Bristol-Myers Squibb
Head Strategy, Operations, Market Access / Emerging Markets
2011 – 2012
BH
Bayer HealthCare
Global Division Head - Diabetes Care
2009 – 2010
NO
Novartis
Head Western/Eastern Europe, Vaccines (incl. Russia, CIS)
2001 – 2009
Key Colleagues at Startups
The people Olivier Jarry works with at each company, as listed on that company's latest Form D.
OS Therapies Inc · Form D, Oct 23, 2026
PR
Paul Romness
Chairman, President and Chief Executive Officer
RP
Robert Petit
Chief Medical Officer and Chief Scientific Officer
FI
Francis Knuettel II
Chief Financial Officer
JC
John Ciccio
Director
AD
Avril McKean Dieser
Director
CE
Craig Eagle
Director
TS
Theodore Search
Director
KC
Kerry Clem
Chief Commercial Officer
Klothea Bio, Inc. · Form D/A, Sep 8, 2026
WS
Walter Schmidt
Director
Petr Sramek
Director
AI
Agustin Fernandez Santana III
Executive officer and director
JM
Jeffrey Madden
President and director